Equity Overview
Price & Market Data
Price: $4.98
Daily Change: -$0.16 / 3.21%
Range: $4.80 - $5.40
Market Cap: $178,980,208
Volume: 203,006
Performance Metrics
1 Week: 73.22%
1 Month: 6.87%
3 Months: -16.86%
6 Months: -21.83%
1 Year: -21.83%
YTD: -10.75%
Company Details
Employees: 136
Sector: Health technology
Industry: Medical specialties
Country: Australia
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.